Pito Chickering
Stock Analyst at Deutsche Bank
(4.50)
# 1,085
Out of 5,090 analysts
370
Total ratings
60.2%
Success rate
10%
Average return
Main Sectors:
Stocks Rated by Pito Chickering
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLCO Bausch + Lomb | Reiterated: Hold | $16 → $20 | $20.00 | - | 8 | Oct 29, 2026 | |
| BSX Boston Scientific | Reiterated: Buy | $60 → $48 | $41.98 | +14.34% | 19 | Oct 29, 2026 | |
| LH Labcorp Holdings | Reiterated: Hold | $306 → $355 | $361.39 | -1.77% | 15 | Oct 29, 2026 | |
| EHC Encompass Health | Reiterated: Buy | $95 → $142 | $135.90 | +4.49% | 16 | Sep 18, 2026 | |
| MDT Medtronic | Rated: Hold | $85 → $92 | $96.54 | -4.70% | 22 | Sep 3, 2026 | |
| MMED MiniMed Group | Rated: Buy | $20 → $25 | $18.28 | +36.76% | 2 | Sep 2, 2026 | |
| MDLN Medline | Rated: Hold | $42 → $37 | $32.12 | +15.19% | 4 | Aug 6, 2026 | |
| ZBH Zimmer Biomet Holdings | Reiterated: Hold | $107 → $98 | $94.52 | +3.68% | 18 | Aug 6, 2026 | |
| DVA DaVita | Rated: Buy | $220 → $265 | $187.50 | +41.33% | 22 | Aug 5, 2026 | |
| MD Pediatrix Medical Group | Rated: Hold | $19 → $25 | $29.82 | -16.16% | 20 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $60 → $70 | $66.89 | +4.65% | 8 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 → $27 | $23.00 | +17.39% | 16 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $26 → $24 | $31.83 | -24.60% | 18 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $441 → $476 | $473.19 | +0.59% | 21 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $32 | $29.96 | +6.81% | 24 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $402 → $315 | $291.86 | +7.93% | 19 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9.5 | $5.81 | +63.51% | 18 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $11.41 | +92.81% | 1 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $12 | $13.16 | n/a | 11 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 → $94 | $92.01 | n/a | 20 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $136 → $178 | $251.82 | n/a | 14 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 → $2.85 | $0.2469 | n/a | 8 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $205 → $241 | $318.95 | n/a | 12 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $208 → $240 | $176.05 | n/a | 16 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $155 | $273.25 | n/a | 17 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $62 | $20.59 | n/a | 1 | Apr 19, 2021 |
Bausch + Lomb
Oct 29, 2026
Reiterated: Hold
Price Target: $16 → $20
Current: $20.00
Upside: -
Boston Scientific
Oct 29, 2026
Reiterated: Buy
Price Target: $60 → $48
Current: $41.98
Upside: +14.34%
Labcorp Holdings
Oct 29, 2026
Reiterated: Hold
Price Target: $306 → $355
Current: $361.39
Upside: -1.77%
Encompass Health
Sep 18, 2026
Reiterated: Buy
Price Target: $95 → $142
Current: $135.90
Upside: +4.49%
Medtronic
Sep 3, 2026
Rated: Hold
Price Target: $85 → $92
Current: $96.54
Upside: -4.70%
MiniMed Group
Sep 2, 2026
Rated: Buy
Price Target: $20 → $25
Current: $18.28
Upside: +36.76%
Medline
Aug 6, 2026
Rated: Hold
Price Target: $42 → $37
Current: $32.12
Upside: +15.19%
Zimmer Biomet Holdings
Aug 6, 2026
Reiterated: Hold
Price Target: $107 → $98
Current: $94.52
Upside: +3.68%
DaVita
Aug 5, 2026
Rated: Buy
Price Target: $220 → $265
Current: $187.50
Upside: +41.33%
Pediatrix Medical Group
Aug 5, 2026
Rated: Hold
Price Target: $19 → $25
Current: $29.82
Upside: -16.16%
Aug 3, 2026
Rated: Buy
Price Target: $60 → $70
Current: $66.89
Upside: +4.65%
Jul 31, 2026
Reiterated: Hold
Price Target: $20 → $27
Current: $23.00
Upside: +17.39%
Jul 30, 2026
Downgraded: Hold
Price Target: $26 → $24
Current: $31.83
Upside: -24.60%
Jul 27, 2026
Rated: Buy
Price Target: $441 → $476
Current: $473.19
Upside: +0.59%
May 1, 2026
Reiterated: Buy
Price Target: $26 → $32
Current: $29.96
Upside: +6.81%
May 1, 2026
Reiterated: Hold
Price Target: $402 → $315
Current: $291.86
Upside: +7.93%
Feb 25, 2026
Reiterated: Hold
Price Target: $9.5
Current: $5.81
Upside: +63.51%
Jan 5, 2026
Initiated Coverage: Buy
Price Target: $22
Current: $11.41
Upside: +92.81%
Sep 15, 2025
Reiterated: Buy
Price Target: $7 → $12
Current: $13.16
Upside: n/a
Jul 25, 2025
Reiterated: Buy
Price Target: $85 → $94
Current: $92.01
Upside: n/a
Jul 23, 2025
Reiterated: Hold
Price Target: $136 → $178
Current: $251.82
Upside: n/a
Feb 28, 2025
Downgraded: Hold
Price Target: $5 → $2.85
Current: $0.2469
Upside: n/a
Oct 31, 2024
Reiterated: Buy
Price Target: $205 → $241
Current: $318.95
Upside: n/a
Oct 28, 2024
Reiterated: Buy
Price Target: $208 → $240
Current: $176.05
Upside: n/a
Jul 24, 2024
Rated: Buy
Price Target: $155
Current: $273.25
Upside: n/a
Apr 19, 2021
Reiterated: Hold
Price Target: $62
Current: $20.59
Upside: n/a